United States
Patients Healthcare Professionals

Pipeline

United States
Canada
Europe
Candidate | indication
Pre-Clinical
Phase I
Phase II
Phase II/III
Phase III
Regulatory Review
Approval
Market
Dermadexin/Pruridexin
Seborrheic Dermatitis / Chronic Pruritus
CF101 (Canfite)
Plaque Psoriasis
CF101
Rheumatoid Arthritis
ASF-1096
Discoid Lupus Erythematosus
Tattoo Removal Cream
Tattoo Removal
Trulance
Chronic Idiopathic Constipation & Irritable Bowel Syndrome with Constipation in Adults